Feb 14, 2023
First Study Participant Enrolled in Clinical Trial of Self-Managed SUI Pessary
Liv Labs Inc., a consumer healthtech company making solutions for urinary incontinence, announces that on February 13, 2023 the first study participant enrolled in the Pippa Pessary Study, a pivotal clinical trial to evaluate the...
Dec 5, 2022
Liv Labs Selected for MATTER’s Inaugural 51 Labs Menopause Accelerator
Liv Labs Inc. joins the inaugural cohort of 51 Labs, sponsored by MATTER, the premier healthcare incubator and innovation hub, alongside Astellas Pharma US, Walgreens, BayCare, Parkview Health, University of Chicago Medicine and Capita3.